rethinkTHC Search
Menu
Study breakdown

CBD's Anti-Addiction Effects on Methamphetamine Work Through Hippocampal Dopamine Receptors

Animal StudyPreliminary evidence
The takeaway

CBD's ability to speed up extinction and prevent reinstatement of methamphetamine-seeking behavior in rats was partially blocked when D2 dopamine receptors in the hippocampus were inhibited.

Addiction neuroscientists, CBD therapeutic researchers, clinicians interested in meth use disorder treatment.

CBD's anti-meth addiction effects were partially blocked by hippocampal D2 receptor inhibition

What the researchers found

A D2-like receptor antagonist (Sulpiride) at 1 and 4 micrograms significantly attenuated CBD's acceleration of methamphetamine conditioned place preference extinction (p<0.01, p<0.05). During reinstatement, the same doses reversed CBD's prevention of reward-seeking behavior (p<0.05, p<0.001), indicating CBD's anti-addiction effects are partially mediated through hippocampal D2 receptors.

Why it matters

Methamphetamine use disorder has no approved pharmacological treatments. This study identifies a specific brain mechanism (hippocampal D2 receptors) through which CBD exerts its anti-addiction effects, potentially informing more targeted therapeutic development.

The numbers in context

Sulpiride 1 and 4 micrograms attenuated CBD extinction effects (p<0.01, p<0.05); Sulpiride reversed CBD reinstatement prevention (p<0.05, p<0.001); CBD 10 micrograms for extinction, 50 micrograms for reinstatement; 10-day extinction period.

How the study worked

Rats received Sulpiride (D2 antagonist, 0.25-4 micrograms) into the hippocampal CA1 region before CBD (ICV) during a 10-day methamphetamine CPP extinction period or on reinstatement day. CBD doses were 10 micrograms (extinction) and 50 micrograms (reinstatement).

What this study cannot tell us

Animal model with direct brain injection of CBD, which differs from how humans consume CBD. CPP is a model of drug reward but does not capture all aspects of human addiction. Results from one brain region may not explain CBD's full anti-addiction profile.

How to read the evidence

Preliminary: Mechanistic animal study using direct brain injections; provides important pathway evidence but requires translation to human-relevant delivery and models.

When this study was published

Published in 2025.

The bigger picture

CBD has shown promise for various substance use disorders in preclinical models, but the mechanisms have been unclear. This study pins one mechanism to D2 receptors in the hippocampus, a brain region critical for drug-related memory processing.

Questions still open

  • Would oral or systemic CBD produce the same hippocampal D2-mediated effects? Are other brain regions also involved in CBD's anti-meth effects? Could these findings inform CBD dosing strategies for human meth addiction trials?

Common questions

Could CBD help people quit methamphetamine?
This animal study provides mechanistic evidence that CBD affects meth-related brain pathways, but direct brain injection in rats is very different from human CBD use. Clinical trials in humans would be needed before any conclusions about treating meth addiction with CBD.
Why do D2 receptors in the hippocampus matter?
D2 dopamine receptors in the hippocampal CA1 region play a key role in processing drug-related memories and emotional signals. By working through these receptors, CBD may help weaken the memory associations that drive drug-seeking behavior.

Read the original research

Cannabidiol mechanism of action on modulating extinction and reinstatement of methamphetamine-seeking behavior: Targeting D2-like dopamine receptors in the hippocampus.

Journal of psychiatric research, 189, 200-210

Citation

Omidiani, Seyed Erfan; Mohammadi, Mahsa; Seddighfar, Masoud; Azizbeigi, Ronak; Haghparast, Abbas. (2025). Cannabidiol mechanism of action on modulating extinction and reinstatement of methamphetamine-seeking behavior: Targeting D2-like dopamine receptors in the hippocampus.. Journal of psychiatric research, 189, 200-210. https://doi.org/10.1016/j.jpsychires.2025.06.011

Explore the wider topic